Cargando…
Characterization of the serum metabolome following radiation treatment in patients with high-grade gliomas
BACKGROUND: Glioblastomas progress rapidly making response evaluation using MRI insufficient since treatment effects are not detectable until months after initiation of treatment. Thus, there is a strong need for supplementary biomarkers that could provide reliable and early assessment of treatment...
Autores principales: | Mörén, Lina, Wibom, Carl, Bergström, Per, Johansson, Mikael, Antti, Henrik, Bergenheim, A. Tommy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818859/ https://www.ncbi.nlm.nih.gov/pubmed/27039175 http://dx.doi.org/10.1186/s13014-016-0626-6 |
Ejemplares similares
-
Metabolomic Screening of Tumor Tissue and Serum in Glioma Patients Reveals Diagnostic and Prognostic Information
por: Mörén, Lina, et al.
Publicado: (2015) -
Metabolic response patterns in brain microdialysis fluids and serum during interstitial cisplatin treatment of high-grade glioma
por: Björkblom, Benny, et al.
Publicado: (2019) -
Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk
por: Björkblom, Benny, et al.
Publicado: (2016) -
Distinct metabolic hallmarks of WHO classified adult glioma subtypes
por: Björkblom, Benny, et al.
Publicado: (2022) -
Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
por: Wibom, C, et al.
Publicado: (2006)